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LUNG CANCER survival statistics pub-
lished by the Office ofPopulation Censuses
and Surveys (OPCS, 1980, 1982) for
1971-1975 for England and Wales have
not been classified into untreated and
treated groups or into histological groups.
In addition, unlike the lung cancer sur-
vival figures prepared by the End Results
Section of the Biometry Branch of the
National Cancer Institute, now part ofthe
Cancer Surveillance, Epidemiology and
End Results (SEER) program of the
National Cancer Institute (USDHHS,
1976), there is currently no attempt by
OPCS to distinguish between those regis-
trations with and without histological
confirmation. This is a disadvantage in
that registrations without any histological
confirmation cannot be positively identi-
fied as true cancer cases. This study of
3706 histologically confirmed cancer regis-
trations in the North West Thames Region
thus provides survival data for sub-groups
not at present analysed by OPCS although
the raw data are available on an OPCS
cancer abstract card. Excellent follow-up
was achieved in that 97-5% of all
cases were successfully followed-up in
1981-1982.
The North-West Thames Region had
an estimated home population as at 30
June 1977 of 1-6593x 106 males and
1*7731 x 106 females and represents 7% of
the total population of England and
Wales. It is the fourth most highly
populated ofthe 15 regions after the West
Midlands (10.5%), Trent (9.2%) and the
North Western (8.2%) and cancer registra-
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tions are submitted from some 40 hospitals
to the regional registry.
Data were abstracted by one of us
(R.J.W.) from the OPCS cancer abstract
cards held in the registry. On this card
information is required for Treated at this
hospital and for Histology confirmed. These
data were first explicitly requested on the
1976 OPCS cancer abstract card. Prior to
1976 the information Type of growth was
requested only in the form Clinical type of
growth and Histological type of growth, if
known. Histological confirmation of
squamous cell carcinoma, oat cell carcin-
oma and adenocarcinoma could therefore
be assessed for the 1975 records but
whether or not a 1975 registered patient
received treatment could only be assessed
for 3 hospitals in the region. Two,
Harefield and Mount Vernon, recorded
this information for 1975 in the space on
the abstract card headed Notes and for
Westminster the information was recorded
on the reverse of the abstract card copy
retained by Westminster. Data abstrac-
tion was for males and females for
1975-1977 and additionally for females
1978-1979. The sexratio males:femalesfor
lung cancer in England and Wales in 1977
(OPCS, 1982) is 3 7: 1 and the additional 2
years of records for females were obtained
to increase the sample size for analysis,
otherwise a sub-grouping by histology for
females would not have been possible. For
the 2 years 1976-1977 with full data for all
hospitals and both sexes the sex ratio in
the region for histologically confirmed
registrations was 3-5: 1.R. F. MOULD AND R. J. WILLIAMS
Itwould obviously have beenimpossible
in a short space oftime to write for follow-
up to, and receive a reply from, the
appropriate hospital record departments
and general practitioners for those of the
3706 registrations who, according to the
North-West Thames Regional Cancer Reg-
iFtxy records, had not died. However, by
tracing each case using the NHS number
and the facilities of the National Health
Service Central Registry at Southport,
follow-up on whether dead or alive could
be rapidly obtained. Hence, following
record abstraction from the abstract cards
inthe regional registry, aninitial follow-up
was obtained from the NHS Central
Registry in October 1980 with a final
follow-up in February 1982. In addition,
all those registrations alive subsequent to
NHS Central Registry follow-up were also
subjected to a follow-up enquiry to the
cancer registration officers at the hospitals
of treatment.
For registrations recorded as untreated,
additional enquiries were made to the
relevant hospitals to confirm that these
lung cancer cases were in fact untreated.
Also, the untreated cases who were
alive at last NHS Central Registry
follow-up were later individually followed-
up through the cancer registration officers.
For the 667 untreated cancer registrations
only 5 were still alive at last follow-
up.
Survival rate computations were made
using the Hewlett Packard 85 desktop
microprocessor of the Westminster
Hospital Cancer Registry, Mould (1982),
and calculated by a life-table method with
data grouped into equal time intervals.
The relative survival rates were calculated
using the Chester Beatty Research
Institute (1974) Serial Abridged Life
Tables for England and Wales which are
also used by OPCS (1980, 1982).
The age distribution of the 3039 regis-
trations treated for carcinoma of the lung
is remarkably similar for males and
females, with mean ages respectively 64-5
years and 64-2 years. For the 667 un-
treated registrations the mean ages are
some four years older, 68 1 years for both
males and females. These mean ages
compare with 66-9 years and 66-3 years for
the 1977 OPCS cancer incidence data for
males and females, England and Wales,
but are higher than those quoted for the
United States 1961-1973 USDHHS (1976)
which are 62 years for males and 59 years
for females. The mean ages for each sex for
the three main histological groups,
squamous cell carcinoma, oat cell carcin-
oma and adenocarcinoma, do not differ by
greater than 3-5 years.
The crude survival rates for untreated
carcinoma ofthe lung in males and females
are shown in Fig. 1 for 0-12 months. The
one-year relative survival rates for males
and females are 9'9% and 6 1% compared
with the 9-3% and 5.9% crude 1-year
rates.
Fig. 2 shows the crude survival rates for
0-60 months for treated carcinoma of the
lung in males and females. The 5-year
relative survival rates for males and
females are 10.7% and 8.3% compared
with the 8.6% and 7.3% crude 5-year
rates.
Table I shows the crude and relative 1-
year and 5-year survival rates for 3039
treated lung cancer registrations, grouped
by sex and histology. Some publications
use oat carcinoma synonymously with
small cell carcinoma, but since for males
238 registrations were specifically recorded
as oat cell compared with only 29 as small
cell, and for females 196 oat cell compared
with 23 small cell, it was decided to retain
the original record descriptions and
analyse in terms of specified oat cell
carcinoma. Other histological groups such
as large cell carcinoma and alveolar cell
carcinoma were too smallin sample sizefor
analysis.
The most extensive published data on
untreated cancer is due to Greenwood
(1926) and Shimkin (1951) but neither
includes data for untreated lung cancer.
Fig. 1 is therefore the only available series
of published untreated lung cancer
survival rates to date. The 3.4% difference
in 1-year survival rates between males
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TABLE.-Crude and relative percentage survival rates of histologically proven treated lung
cancer, by sex and histological group ( + s.e. is given in brackets for each crude survival
rate)
Histology
Squamous cell ca.
Adenocarcinoma
Oat cell ca.
Squamous cell ca.
Adenocarcinoma
Oat cell ca.
No. of
registrations
1037
164
238
311
90
196
Total =2036
1-year survival rates (%)
Crude Relative
39-1 (±1-5) 41-2
36-0 (± 3-8) 37*3
13-5 (± 2.2) 14-0
34-6 (±2-7) 35*4
28-9 (±4-8) 29-5
14-0 (± 2.5) 14-3
5-year survival rates (%)
Crude Relative
12-4 (±1-1) 15-9
10-8 (±2-5) 13-3
2-3 (± 1-0) 2-9
10-5 (± 2-1) 12-1
16-9 (±4-0) 19-1
3-1 (±1-3) 3-5
UNMREATED LUNG CANCER REGISTRATIONS IN THE NORTH WESTTHAMES REGION
204 Female registrations, 1975 - 1979
463 Male registrations, 1975 - 1979
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FIG. 1.-Crude survival rates of untreated carcinoma of the lung in males and females. The relative
one-year survival rates for males and females are respectively 9-9% and 6-1%. (Note. Crude rates
are plotted in Figures 1 and 2 since these can be computed every month or every 3 months, whereas
relative rates canonly becomputedannuallysince the CBRI (1974) data onlyprovides nPx probabili-
ties for integral numbers of years between one and five.)
and females is probably due to an excess of
oat cell carcinoma registrations in the
female series.
One of the recent clinical trials for
treatment ofsmall cell carcinoma was that
by the Medical Research Council (1979),
and it is interesting to note that they
quote an 18% 1-year survival rate for
patients treated by radiotherapy, ofwhom
66% were aged between 55 and 70 years.
For oat cell carcinoma in the North West
Thames region there is a 13-5% 1-year
survival, Table. Of this group of 238 oat
cell carcinomas in the Table, 87 were in the
age group 58-67 years and the crude 1-
year survival rate for this sub-group was
18-4% (±4-2%), which is in agreement
with the 18% rate for the Medical
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Males Females
Squamous cell ca. 41.9 25.0
Oat cell ca. 11.2 19.1
Adenocarcinoma 4.8 11.8
Small cell ca. 1.3 2.0
Large cell ca. 1.3 1.0
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TREATED LUNG CANCER REGISTRATIONS IN THE NORTH WEST THAMES REGION
945 Female registrations, 1975 - 1979
2094 Male registrations, 1975 - 1977
HISTOLOGICAL DISTRIBUTION
Histological % of Registrations in each
- l group histological group
Males Females
Squamous cell ca. 49.5 32.9
Oat cell ca. 11.4 20.7
Adenocarcinoma 7.8 9.5
Small cell ca. 1.4 2.4
Large cell ca. 2.2 3.0
Alveolar cell ca. 0.5 1.2
Carcinoma, NOS 24.2 26.0
Other histologies 3.0 4.3
- \ NOS = No other specification
MEAN AGE (yrs) % Q,',. ~Males
29.5% 1-year Survival Males Females
(Standard Error = 1.0%) 64.5 64.2
Females ' .-__-
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FIG. 2.-Crude survival rates of treated carcinoma of the lung in males and females. The relative
one-year survival rates for males and females are respectively 30-8% and 25-1%.
Research Council trial. Livingston et al.
(1978) quote a higher 1-year rate of 22%
for 73 cases treated by radiotherapy and
for a series of 479 cases reviewed by
Hansen et al. (1980) which combined
several groups of small cell carcinoma
treated by various chemotherapy or com-
bination radiotherapy regimes, a 21% 18-
month survival is quoted for patients with
regional disease. This compares with 9.4%
and 8.4% 18-month crude survivals in
females and males for the series of 238 and
196 registrations in the Table.
For a disease such as lung cancer, the 5-
year survival rate is clearly not a good
criterion oftreatment success and a 1-year
rate is more realistic. For example, for
both males and females, the improvement
in the 1-year survival rate is some 20%
when the patients are treated, compared
with when they are untreated. Differences
between survivals for males and females is
not large for any histological sub-group.
However, for adenocarcinoma, the 1-year
relative rates differ by more than 5%. In
this instance, males have a 1-year survival
rate 8% higher than for females, although
when the 5-year survival rates are con-
sidered, survival is 6% higher for females
than for males. A similar difference was
also reported in the United States
(USDHHS, 1976), for adenocarcinoma,
1960-1973, with a 10% 5-year relative
survival rate for males and a 14% 5-year
relative survival rate forfemales.
This review refers only to histologically
confirmed registrations since these are
"good" data in that a verified histology
has been recorded in the routine registra-
tion system with sufficient accuracy to
enable a survival analysis by histological
group to be made. Also, the population of
the North West Thames region is such
that the regional data can be regarded
as a reasonably representative sample
from England and Wales. The most
recently published OPCS (1982) survival
statistics for England and Wales are for
1975 and give 20.0% and 17.5% 1-year
relative survival rates for males and
females, and 7.0% and 6.6% 5-year
relative survival rates for males and
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females. These are lower than the rates for
this North West Thames Regional treated
lung cancer series, which have already
been stated as respectively 30 8%, 25-1%,
10.7% and 8.3%. However, this is not
surprising since the OPCS analysis is for a
combined series of treated and untreated
registrations, as well as for histologically
confirmed and unconfirmed registrations.
In the North West Thames Region, a
significant number oflung cancer registra-
tions are untreated and it is probable that
this pattern is repeated throughout
England and Wales. Analysis of lung
cancer registrations for survival patterns
should therefore be made on a basis of
treated and untreated series of cases,
otherwise a combination ofall the registra-
tions cannot be assumed to provide the
best estimate of the overall results of
treatment within a large population such
as a region. When data on histological
verification are recorded this should be
used for survival analysis, rather than be
discarded, as at present occurs at OPCS for
England and Wales.
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